• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续性和阵发性心房颤动患者中心源性脑栓塞并发症的患病率

Prevalence of Cardio-Embolic Brain Complications in Permanent and Paroxysmal Atrial Fibrillation Patients.

作者信息

Rosca Ciprian Ilie, Sharma Abhinav, Nisulescu Daniel-Dumitru, Otiman Gabriela, Duda-Seiman Daniel-Marius, Morariu Stelian Ioan, Lighezan Daniel Florin, Kundnani Nilima Rajpal

机构信息

Centre for Advanced Research in Cardiovascular Pathology and Hemostasis, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Department of Internal Medicine I-Medical Semiotics I, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.

出版信息

Healthcare (Basel). 2023 Jan 6;11(2):175. doi: 10.3390/healthcare11020175.

DOI:10.3390/healthcare11020175
PMID:36673543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9858915/
Abstract

Background: Atrial fibrillation (AF) is the most frequent of all cardiac arrhythmias, with an increasing prevalence in the last 20 years. Cardio-embolic brain complications (CEBC) related to AF often occur or recur, even following appropriate treatment. Method: We conducted a retrospective study and analyzed the presence of stroke, dementia, and Parkinson’s disease (PD) in both paroxysmal and permanent AF patients. The records of 1111 consecutive admitted patients with primary diagnosis of AF at the Municipal Emergency University Hospital, Timisoara, between 2015 and 2016 were examined. Statistical analysis was performed on the patients included in the study based on the inclusion and exclusion criteria. Results: A significant statistical difference was noted among the permanent AF group for stroke (48.75% vs. 26.74%, p < 0.001) and dementia (10.25% vs. 3.86%, p < 0.001) compared to paroxysmal AF patients. Permanent AF patients presented a higher risk of developing stroke, dementia, and PD compared to patients with paroxysmal AF. Meanwhile, male gender and an increase in age showed an increase in the odds of having cardio-embolic brain complications in patients with paroxysmal AF. Conclusion: Based on the results obtained, it can be concluded that the risk of cardio-cerebral embolic complications is greater in permanent AF patients compared to paroxysmal AF cases. Ischemic stroke and dementia are more frequent in the permanent AF group, but analyzing the data regarding the age of onset paroxysmal AF is critical due to the fact that it involves a younger population. Prompt diagnosis and treatment can help significantly in saving stroke patients.

摘要

背景

心房颤动(AF)是所有心律失常中最常见的一种,在过去20年中其患病率呈上升趋势。与AF相关的心脏栓塞性脑并发症(CEBC)经常发生或复发,即使在经过适当治疗后也是如此。方法:我们进行了一项回顾性研究,分析了阵发性和永久性AF患者中中风、痴呆和帕金森病(PD)的情况。检查了2015年至2016年期间在蒂米什瓦拉市立急诊大学医院连续收治的1111例初步诊断为AF的患者的记录。根据纳入和排除标准对纳入研究的患者进行统计分析。结果:与阵发性AF患者相比,永久性AF组在中风(48.75%对26.74%,p<0.001)和痴呆(10.25%对3.86%,p<0.001)方面存在显著统计学差异。与阵发性AF患者相比,永久性AF患者发生中风、痴呆和PD的风险更高。同时,男性性别和年龄增加表明阵发性AF患者发生心脏栓塞性脑并发症的几率增加。结论:根据所得结果,可以得出结论,与阵发性AF病例相比,永久性AF患者发生心脑栓塞并发症的风险更大。缺血性中风和痴呆在永久性AF组中更为常见,但由于阵发性AF涉及较年轻人群,因此分析其发病年龄的数据至关重要。及时诊断和治疗对挽救中风患者有很大帮助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/9858915/e7803c4c39b5/healthcare-11-00175-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/9858915/993cd953ed1a/healthcare-11-00175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/9858915/8beb532bccd3/healthcare-11-00175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/9858915/8854f2fb07b9/healthcare-11-00175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/9858915/e7803c4c39b5/healthcare-11-00175-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/9858915/993cd953ed1a/healthcare-11-00175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/9858915/8beb532bccd3/healthcare-11-00175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/9858915/8854f2fb07b9/healthcare-11-00175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/9858915/e7803c4c39b5/healthcare-11-00175-g004.jpg

相似文献

1
Prevalence of Cardio-Embolic Brain Complications in Permanent and Paroxysmal Atrial Fibrillation Patients.持续性和阵发性心房颤动患者中心源性脑栓塞并发症的患病率
Healthcare (Basel). 2023 Jan 6;11(2):175. doi: 10.3390/healthcare11020175.
2
Differences in oral anticoagulant prescriptions between specialists and non-specialists in patients with cardioembolic stroke caused by non-valvular atrial fibrillation.非瓣膜性心房颤动引起的心源性脑栓塞患者中,专科医生与非专科医生之间的口服抗凝药物处方差异。
Heart Vessels. 2022 May;37(5):867-874. doi: 10.1007/s00380-021-01984-y. Epub 2021 Nov 19.
3
Importance of Paroxysmal Atrial Fibrillation and Sex Differences in the Prevention of Embolic Stroke in Hypertrophic Cardiomyopathy.阵发性心房颤动的重要性及肥厚型心肌病患者预防栓塞性卒中的性别差异
Circ Rep. 2021 Apr 6;3(5):273-278. doi: 10.1253/circrep.CR-20-0101.
4
L-arginine pathway metabolites can discriminate paroxysmal from permanent atrial fibrillation in acute ischemic stroke.L-精氨酸途径代谢物可区分急性缺血性卒中患者的阵发性房颤与永久性房颤。
Ideggyogy Sz. 2019 Mar 30;72(3-4):79-88. doi: 10.18071/isz.72.0079.
5
Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.波兰单一地区医院临床实践中的房颤患者卒中预防的抗凝和抗血小板治疗。
Kardiol Pol. 2013;71(12):1260-5. doi: 10.5603/KP.a2013.0179. Epub 2013 Aug 30.
6
Detection of paroxysmal atrial fibrillation or flutter in patients with acute ischemic stroke or transient ischemic attack by Holter monitoring.通过动态心电图监测检测急性缺血性卒中或短暂性脑缺血发作患者的阵发性心房颤动或心房扑动。
Indian Heart J. 2014 Mar-Apr;66(2):188-92. doi: 10.1016/j.ihj.2014.02.009. Epub 2014 Mar 4.
7
The type of atrial fibrillation is associated with long-term outcome in patients with acute ischemic stroke.心房颤动的类型与急性缺血性脑卒中患者的长期预后相关。
Int J Cardiol. 2013 Aug 20;167(4):1519-23. doi: 10.1016/j.ijcard.2012.04.131. Epub 2012 May 17.
8
Selecting the right anticoagulant for stroke prevention in atrial fibrillation.选择合适的抗凝药物预防房颤相关性卒中。
Eur Rev Med Pharmacol Sci. 2021 Jul;25(13):4499-4505. doi: 10.26355/eurrev_202107_26241.
9
A Simple Score That Predicts Paroxysmal Atrial Fibrillation on Outpatient Cardiac Monitoring after Embolic Stroke of Unknown Source.一个用于预测不明来源栓塞性卒中后门诊心脏监测阵发性心房颤动的简单评分
J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1692-1696. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.028. Epub 2018 Feb 28.
10
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.在欧洲,阵发性与非阵发性心房颤动患者的“真实世界”管理和结局:EURObservational Research Programme - Atrial Fibrillation(EORP-AF)一般试点登记研究。
Europace. 2016 May;18(5):648-57. doi: 10.1093/europace/euv390. Epub 2016 Jan 29.

引用本文的文献

1
Combined Predictive Value of Neutrophil-to-Lymphocyte Ratio and CHA2DS2-VASc Score for Cardiogenic Cerebral Embolism in NVAF Patients.中性粒细胞与淋巴细胞比值和CHA2DS2-VASc评分对非瓣膜性房颤患者心源性脑栓塞的联合预测价值
Int J Gen Med. 2025 Jun 27;18:3489-3499. doi: 10.2147/IJGM.S523480. eCollection 2025.
2
Importance of H-FABP in Early Diagnosis of Acute Myocardial Infarction.H-FABP在急性心肌梗死早期诊断中的重要性。
Int J Gen Med. 2024 Sep 24;17:4335-4346. doi: 10.2147/IJGM.S476736. eCollection 2024.
3
Use of Neutrophil-to-Lymphocyte Ratio to Predict In-Hospital Mortality in Patients Admitted with Acute Decompensation of Atrial Fibrillation.

本文引用的文献

1
Atrial Fibrillation Related and Unrelated Stroke Recurrence Among Ischemic Stroke Patients With Atrial Fibrillation.心房颤动相关和非相关的缺血性卒中合并心房颤动患者的卒中复发情况
Front Neurol. 2021 Oct 21;12:744607. doi: 10.3389/fneur.2021.744607. eCollection 2021.
2
Costs of Stroke and Incidence of First Diagnosis of Atrial Fibrillation at Time of Stroke. Neurology Ward Hospital Poznań, Poland 2018.中风的成本以及中风时首次诊断心房颤动的发生率。波兰波兹南神经病学病房医院,2018年。
Healthcare (Basel). 2021 Aug 5;9(8):999. doi: 10.3390/healthcare9080999.
3
Impact of the Pattern of Atrial Fibrillation on Stroke Risk and Mortality.
利用中性粒细胞与淋巴细胞比值预测心房颤动急性失代偿患者的院内死亡率
J Clin Med. 2024 Aug 12;13(16):4719. doi: 10.3390/jcm13164719.
4
Genotype-Phenotype Insights of Inherited Cardiomyopathies-A Review.遗传性心肌病的基因型-表型见解——综述
Medicina (Kaunas). 2024 Mar 27;60(4):543. doi: 10.3390/medicina60040543.
5
Does COVID-19 Infection during Pregnancy Increase the Appearance of Congenital Gastrointestinal Malformations in Neonates?孕期感染新冠病毒会增加新生儿先天性胃肠道畸形的发生率吗?
Biomedicines. 2023 Nov 21;11(12):3105. doi: 10.3390/biomedicines11123105.
6
Exploring the Link between Cardiorenal and Metabolic Diseases.探索心肾疾病与代谢性疾病之间的联系。
Healthcare (Basel). 2023 Oct 26;11(21):2831. doi: 10.3390/healthcare11212831.
心房颤动模式对卒中风险和死亡率的影响。
Arrhythm Electrophysiol Rev. 2021 Jul;10(2):68-76. doi: 10.15420/aer.2021.01.
4
Ischemic Stroke Risk Factors in Patients with Atrial Fibrillation Treated with New Oral Anticoagulants.新型口服抗凝剂治疗的心房颤动患者的缺血性卒中危险因素
J Clin Med. 2021 Mar 16;10(6):1223. doi: 10.3390/jcm10061223.
5
Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation.持续性或永久性心房颤动与非瓣膜性心房颤动患者的严重心源性栓塞性卒中相关。
Thromb J. 2021 Mar 31;19(1):22. doi: 10.1186/s12959-021-00276-9.
6
Initiation of Guideline-Matched Oral Anticoagulant in Atrial Fibrillation-Related Stroke.心房颤动相关性卒中患者启动符合指南的口服抗凝治疗
J Stroke. 2021 Jan;23(1):113-123. doi: 10.5853/jos.2020.03440. Epub 2021 Jan 31.
7
Increased atrial fibrillation risk in Parkinson's disease: A nationwide population-based study.帕金森病患者心房颤动风险增加:一项全国范围内基于人群的研究。
Ann Clin Transl Neurol. 2021 Jan;8(1):238-246. doi: 10.1002/acn3.51279. Epub 2021 Jan 3.
8
Type of atrial fibrillation and outcomes in patients without oral anticoagulants.无口服抗凝剂患者的房颤类型与结局。
Clin Cardiol. 2021 Feb;44(2):168-175. doi: 10.1002/clc.23519. Epub 2020 Dec 12.
9
Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation.在真实世界中应用口服抗凝药物治疗伴有器械检测到的心房颤动患者。
J Am Heart Assoc. 2020 Dec 15;9(24):e018378. doi: 10.1161/JAHA.120.018378. Epub 2020 Nov 30.
10
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.